Evidence map›Paper›PMID 30441840›Full record

ArticleBiomolecules2018

Oxidation of 5-methylaminomethyl uridine (mnm⁵U) by Oxone Leads to Aldonitrone Derivatives.

Qishun Zhou, Bao Tram Vu Ngoc, Grazyna Leszczynska, Jean-Luc Stigliani, Geneviève Pratviel

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Qishun ZhouCNRS, Laboratoire de Chimie de Coordination, 205 route de Narbonne, 31077 Toulouse CEDEX4, France. qishun.zhou@univ-tlse3.fr.
Bao Tram Vu NgocCNRS, Laboratoire de Chimie de Coordination, 205 route de Narbonne, 31077 Toulouse CEDEX4, France. bao-tram.vu-ngoc@univ-tlse3.fr.
Grazyna LeszczynskaInstitute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland. grazyna.leszczynska@p.lodz.pl.ORCID 0000-0002-6874-022X
Jean-Luc StiglianiCNRS, Laboratoire de Chimie de Coordination, 205 route de Narbonne, 31077 Toulouse CEDEX4, France. jean-luc.stigliani@lcc-toulouse.fr.
Geneviève PratvielCNRS, Laboratoire de Chimie de Coordination, 205 route de Narbonne, 31077 Toulouse CEDEX4, France. genevieve.pratviel@lcc-toulouse.fr.ORCID 0000-0003-0688-2107
Centre National de la Recherche Scientifique · FRLodz University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative RNA damage is linked to cell dysfunction and diseases. The present work focuses on the in vitro oxidation of 5-methylaminomethyl uridine (mnm⁵U), which belongs to the numerous post-transcriptional modifications that are found in tRNA. The reaction of oxone with mnm⁵U in water at pH 7.5 leads to two aldonitrone derivatives. They form by two oxidation steps and one dehydration step. Therefore, the potential oxidation products of mnm⁵U in vivo may not be only aldonitrones, but also hydroxylamine and imine derivatives (which may be chemically more reactive). Irradiation of aldonitrone leads to unstable oxaziridine derivatives that are susceptible to isomerization to amide or to hydrolysis to aldehyde derivative.

Indexed as

AldehydesDarknessMolecular ConformationOxidation-ReductionPhotochemical ProcessesProton Magnetic Resonance SpectroscopySpectrophotometry, UltravioletSulfuric AcidsUridine5-methylaminomethyluridineAldehydespotassium peroxymonosulfuric acidSulfuric AcidsUridinealdonitoneKHSO5oxaziridineRNA oxidationwater solvent

Identifiers

PMID30441840
PMCPMC6315764
OpenAlexW2901205586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.